About Modi-Mundipharma Private Limited
Data last updated:
Modi-Mundipharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 31 October 1990 and has been in existence for over 36 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1990PTC041928. Its GSTIN is 07AAACM2303F1Z4 (Delhi). The company holds 22 GST registrations, of which 20 are active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹30 Lakh. It was formerly known as Modi-Mundipharma Limited. It is led by directors including Abhishek Modi and Kumkum Modi.
Its last annual general meeting (AGM) was held on 31 December 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 1400 Modi Tower 98 Nehru Place, New Delhi, Delhi, India – 110019.
As per the financials filed for FY 2025, the company reported a revenue of ₹1,314.82 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹36.73 Cr (net margin 2.8%) and EBITDA of ₹133.17 Cr (EBITDA margin 10.1%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 7% over five years.
Its group structure includes 3 subsidiaries.
As per MCA filings, the company has open charges of ₹251.75 Cr and satisfied charges of ₹198.98 Cr on record. Court records list 59 cases involving the company, including 39 filed by the company and 20 filed against it; 6 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website umeshmodigroup.com.
Company details
Contact details
Modi-Mundipharma Private Limited's registered office is in New Delhi, Delhi. Its website is umeshmodigroup.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address1400 Modi Tower 98 Nehru Place, New Delhi, Delhi, India – 110019
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Modi-Mundipharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activities of Modi-Mundipharma are manufacturing and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and wholesale trading. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Modi-Mundipharma Private Limited, buy the company report.
Financials of Modi-Mundipharma Private Limited
FY 2024 filings availableModi-Mundipharma Private Limited reported revenue of ₹1,314.82 Cr (up 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 7% over five years, including 7% growth in the latest year. EBITDA rose 43% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹133.17 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹36.73 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.1% | ||||
| Net Profit Margin | 2.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Modi-Mundipharma Private Limited, buy the company report.
Board of directors of Modi-Mundipharma Private Limited
Modi-Mundipharma has 7 current directors and 14 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Abhishek Modi Also directs: Sbec Sugar Limited, Bihar Sponge Iron Limited, Modi Illva India Private Limited and 5 more | Director | 15 Feb 1995 | 31 Years 8 Months | Current |
| Kumkum Modi | Director | 28 Apr 1993 | 33 Years 5 Months | Current |
| Umesh Kumar Modi | Director | 31 Oct 1990 | 35 Years 11 Months | Current |
| Meghna Modi | Director | 25 Mar 1991 | 35 Years 6 Months | Current |
| Jayesh Modi | Director | 13 Sep 2012 | 14 Years 1 Months | Current |
| Bryan George Lea | Director | 04 Jun 2018 | 8 Years 4 Months | Current |
Auditor
Modi-Mundipharma Private Limited is audited by SARAT JAIN & ASSOCIATES. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SARAT JAIN & ASSOCIATES. | FY 2023 | 014793C |
Shareholding
The shareholding of Modi-Mundipharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Modi-Mundipharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Feb 2021 | 100427249 | Hdfc Bank Limited | ₹10 Cr | Open | |
| 12 Jul 2017 | 100119536 | Hdfc Bank Limited | ₹2.1 Cr | Open | |
| 12 Jul 2017 | 100119535 | Hdfc Bank Limited | ₹16.64 Cr | Open | |
| 10 Feb 2014 | 10481271 | Others | ₹223.01 Cr | Open | |
| 14 Apr 2022 | 100566726 | Others | ₹5 Cr | Satisfied |
To see the full charge records of Modi-Mundipharma Private Limited, buy the company report.
Total charge records: 10 View all charges
Legal cases
Modi-Mundipharma Private Limited has 59 court cases on record: 39 filed by Modi-Mundipharma, 20 filed against it. 6 cases are pending and 53 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 28 | 11 | 3 |
| High courts | 26 | 6 | 3 |
| Supreme Court | 5 | 3 | 0 |
Cases on record (5 of 59)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed by the company against Care Formulation Labs Pvt. Ltd. & Anr. | Pending |
| High Court of Delhi | Commercial suit | Filed by the company against Arlak Biotech Private Limited & Anr. | Pending |
| Supreme Court | Court case (Special Leave Petition (Civil)) | Filed against the company by Speciality Meditech Pvt. Ltd. | Disposed |
| High Court of Delhi | Commercial suit | Filed by the company against Agrosaf Pharmaceuticals Pvt. Ltd. & Anr. | Disposed |
| High Court of Delhi | Commercial suit | Filed by the company against Lloyd Health Care Pvt. Ltd. & Anr. | Disposed |
To see the full case history of Modi-Mundipharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Modi-Mundipharma Private Limited was last rated by Crisil on 13 Jul 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 13 Jul 2020 |
To see the full credit ratings and regulatory alerts of Modi-Mundipharma Private Limited, buy the company report.
MSME payment delays
Modi-Mundipharma Private Limited has 5 MSME Form 1 returns on record between 2019 and 2020, listing 170 overdue payments to 14 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 14)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Denave India Private Limited | |||
| Vista Retail Private Limited | |||
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Modi-Mundipharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Modi-Mundipharma has 3 subsidiary companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Modi-Mundipharma Healthcare Private Limited | U24100DL2009PTC188842 | |
| Win-Medicare Private Limited | U51397DL1981PTC011647 | |
| Modi-Mundipharma Beauty Products Private Limited | U74899DL1994PTC057763 |
To see the full group structure of Modi-Mundipharma Private Limited, buy the company report.
GST
Modi-Mundipharma has 22 GST registrations: 20 active and 2 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACM2303F1Z4 | Delhi | Active | 01 Jul 2017 |
| 07AAACM2303F2Z3 | Delhi | Active | 24 Aug 2017 |
| 03AAACM2303F1ZC | Punjab | Active | 01 Jul 2017 |
| 05AAACM2303F1Z8 | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Modi-Mundipharma Private Limited, buy the company report.
Recent activity
Modi-Mundipharma Private Limited has 20 board changes on record since 1990: 7 appointments and 13 cessations. The latest: Vijay Kumar Modi was appointed as Additional Director on 12 Aug 2025.
32 earlier events are in the company report.
Frequently asked questions
Modi-Mundipharma is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 31 October 1990 (36+ years old) and is registered under CIN U74899DL1990PTC041928.
Modi-Mundipharma has 7 current directors:
- Abhishek Modi - Director
- Kumkum Modi - Director
- Umesh Kumar Modi - Director
- Meghna Modi - Director
- Jayesh Modi - Director
- Bryan George Lea - Director
- Vijay Kumar Modi - Additional Director
The latest financial statements of Modi-Mundipharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 31 December 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Modi-Mundipharma is 07AAACM2303F1Z4, registered in Delhi. The company has 22 GST registrations in all, of which 20 are active and 2 are cancelled or inactive. Other active GSTINs include 07AAACM2303F2Z3 (Delhi), 03AAACM2303F1ZC (Punjab), 05AAACM2303F1Z8 (Uttarakhand).
The CIN (Corporate Identification Number) of Modi-Mundipharma is U74899DL1990PTC041928. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Modi-Mundipharma has 59 court cases on record: 39 filed by the company and 20 filed against it. 6 are pending. Most are in the district courts.
Modi-Mundipharma was incorporated on 31 October 1990, making it 36+ years old. It is registered with the Registrar of Companies, Delhi.
Vijay Kumar Modi was appointed as Additional Director on 12 Aug 2025. Jagan Nath Khurana ceased to be Alternate Director on 29 Dec 2020. Stuart David Baker ceased to be Director on 31 Dec 2019. Modi-Mundipharma has 20 board changes on record in total.
Modi-Mundipharma has 5 MSME Form 1 returns on record between 2019 and 2020, listing 170 overdue payments to 14 micro and small suppliers. The latest return was filed on 13 May 2021.
Modi-Mundipharma can be reached through the website umeshmodigroup.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Modi-Mundipharma is at 1400 Modi Tower 98 Nehru Place, New Delhi, Delhi, India – 110019.